HistoSonics Valued at $2B+ in Deal with Investors Including K5, Bezos

HistoSonics valued at $2B+ in deal with investors including K5, Bezos

HistoSonics is developing ultrasound technology to destroy liver tumors and has landed several big-dollar rounds of capital investment in recent years.

HistoSonics Acquired by Investor Consortium - Endovascular Today

August 7, 2025—HistoSonics, the developer of the Edison histotripsy system and histotripsy therapy platform, announced a management-led majority stake acquisition by a syndicate of private and public investors, including K5 Global, Bezos Expeditions, Wellington Management, and other new and existing investors. According to the company, the transaction values HistoSonics at approximately $2.25 billion and positions the company for accelerated gro…